Nothing Special   »   [go: up one dir, main page]

Ivashchenko et al., 2017 - Google Patents

Self-organizing silver and ultrasmall iron oxide nanoparticles prepared with ginger rhizome extract: Characterization, biomedical potential and microstructure analysis …

Ivashchenko et al., 2017

Document ID
4400245826443012916
Author
Ivashchenko O
Gapiński J
Peplińska B
Przysiecka
Zalewski T
Nowaczyk G
Jarek M
Marcinkowska-Gapińska A
Jurga S
Publication year
Publication venue
Materials & Design

External Links

Snippet

Multimodal nanoparticles (NPs) that may be used for therapies and diagnostics is the most promising trend for efficient therapy. We demonstrate that nanocomposite based on self- organizing silver and ultrasmall magnetic iron oxide NPs (MAg) produced in one-step …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients

Similar Documents

Publication Publication Date Title
Ivashchenko et al. Self-organizing silver and ultrasmall iron oxide nanoparticles prepared with ginger rhizome extract: Characterization, biomedical potential and microstructure analysis of hydrocolloids
Bharadwaj et al. Green synthesis of gold nanoparticles using plant extracts as beneficial prospect for cancer theranostics
Ferreira et al. The role of magnetic nanoparticles in cancer nanotheranostics
Jabir et al. Supermagnetic Fe3O4-PEG nanoparticles combined with NIR laser and alternating magnetic field as potent anti-cancer agent against human ovarian cancer cells
Ding et al. Shape-controlled fabrication of magnetite silver hybrid nanoparticles with high performance magnetic hyperthermia
Mahmoudi et al. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat
Kihara et al. Effect of composition, morphology and size of nanozeolite on its in vitro cytotoxicity
Zaloga et al. Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting
Thorat et al. Superparamagnetic gadolinium ferrite nanoparticles with controllable curie temperature–cancer theranostics for MR‐imaging‐guided magneto‐chemotherapy
Simon et al. Copper nanocluster-doped luminescent hydroxyapatite nanoparticles for antibacterial and antibiofilm applications
Anbouhi et al. Albumin binding, anticancer and antibacterial properties of synthesized zero valent iron nanoparticles
Arsalan et al. Exploring the interaction of cobalt oxide nanoparticles with albumin, leukemia cancer cells and pathogenic bacteria by multispectroscopic, docking, cellular and antibacterial approaches
Zhu et al. Cobalt nanowire-based multifunctional platform for targeted chemo-photothermal synergistic cancer therapy
Jabir et al. Gold nanoparticles loaded TNF-α and CALNN peptide as a drug delivery system and promising therapeutic agent for breast cancer cells
Hsiao et al. Preparation and characterization of multifunctional mesoporous silica nanoparticles for dual magnetic resonance and fluorescence imaging in targeted cancer therapy
Joseph et al. Exploration of biogenic nano-chemobiotics fabricated by silver nanoparticle and galactoxyloglucan with an efficient biodistribution in solid tumor investigated by SERS fingerprinting
Cui et al. Preparation of graphene oxide with silver nanowires to enhance antibacterial properties and cell compatibility
Wu et al. The anticancer properties of iron core–gold shell nanoparticles in colorectal cancer cells
Rabel et al. A green chemistry to produce iron oxide–Chitosan nanocomposite (CS-IONC) for the upgraded bio-restorative and pharmacotherapeutic activities-Supra molecular nanoformulation against drug-resistant pathogens and malignant growth
US20120251450A1 (en) Nanoparticles that preferentially associate with and kill diseased cells for diagnostic and therapeutic applications
Fiaz et al. Green synthesis of cobalt ferrite and Mn doped cobalt ferrite nanoparticles: Anticancer, antidiabetic and antibacterial studies
Liu et al. Improved delivery system for celastrol-loaded magnetic Fe3O4/α-Fe2O3 heterogeneous nanorods: HIF-1α-related apoptotic effects on SMMC-7721 cell
Iqbal et al. Facile synthesis of biocompatible magnetic titania nanorods for T 1-magnetic resonance imaging and enhanced phototherapy of cancers
Jin et al. Gadolinium silicate-coated porous silicon nanoparticles as an MRI contrast agent and drug delivery carrier
Lazar et al. Novel drug carrier: 5-Fluorouracil formulation in nanoporous biogenic Mg-calcite from blue crab shells—Proof of concept